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In contrast to the positive association found in three studies between maternal anaemia during pregnancy and childhood leukaemia,
no such association was found in infant leukaemia (odds ratio 0.85, 95% confidence interval 0.53–1.37).
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Maternal anaemia during pregnancy has been positively associated
with childhood leukaemia in three studies (Petridou et al, 1997;
Roman et al, 1997; Roman et al, 2005). Given the positive
associations between maternal anaemia and high birth weight
(Steer et al, 1995; Malhotra et al, 2002; Chang et al, 2003) and high
birth weight and infant leukaemia (Hjalgrim et al, 2003), we
hypothesised that there may also be a positive association between
maternal anaemia during pregnancy and infant leukaemia. We
used data from the Children’s Oncology Group’s (COG) protocol
AE24, a North American case–control study designed to evaluate
possible risk factors for infant leukaemia. This is the first study
limiting the evaluation of maternal anaemia to its effects on infant
leukaemia, a distinct type of childhood leukaemia.
METHODS AND MATERIALS
The human subject protection committees of each participating
COG institution approved the study protocol. Eligibility criteria for
cases included: (1) diagnosis with acute leukaemia in the first year
of life between 1 January 1996 and 20 August 2002; (2) an English-
speaking biological mother available for a telephone interview and
(3) no Down syndrome. Controls were identified and contacted by
random digit dialling (RDD) (for more details see Spector et al,
2005).
Mothers were interviewed on demographic aspects, possible
exposures and birth characteristics of the index child. Separate
informed consent was obtained for access to the mother’s medical
records for 6 months prior to the index pregnancy up through 1
week after the birth or discharge from the hospital. Maternal
haemoglobin concentrations, red cell indices and the date the
blood was drawn were abstracted from the medical record. Reports
of leukaemia cell cytogenetic and molecular abnormalities were
obtained from the treating COG institution.
A total of 348 eligible cases were identified at 126 participating
COG institutions. Maternal interviews were completed for 240
cases (69%). Using RDD, a total of 430 households were identified
with a child eligible as a control. Interviews were completed for 255
of the 430 eligible controls, an RDD response rate of 59%. Medical
records were obtained for 236 case mothers and 215 control
mothers.
Statistical evaluation was performed using SAS version 9.1, with
odds ratios (ORs) calculated using unconditional logistic regres-
sion, for all infant leukaemia cases and leukaemia subtypes defined
by leukaemia type (acute lymphoblastic leukaemia (ALL) vs acute
myeloid leukaemia (AML)) and the presence of MLL gene
rearrangements (MLLþ vs MLL ). Potential confounders eval-
uated were maternal age at time of index child’s birth, maternal
race and education, household income, smoking during preg-
nancy, birth order of the child, birth weight and child gender.
All mothers with an available haemoglobin value were included
in the analysis. Anaemia was defined as a haemoglobin concentra-
tion of o11gdl
 1 (World Health Organization (WHO) classifica-
tion, WHO expert committee, 1965), but a stricter definition was
also used (haemoglobin o10gdl
 1). Haemoglobin concentration
was also analysed as both a categorical and continuous exposure.
A more specific analysis was performed using the physiologic
anaemia of pregnancy, a normal drop in haemoglobin due to
plasma volume expansion, as the exposure of interest. This
anaemia, which presents in the second or third trimester, is
intriguing because it is associated with the highest average birth
weight (Steer, 2000). Physiologic anaemia of pregnancy was
defined as haemoglobin of o11gdl
 1 that developed in the
second or third trimester. First trimester anaemia is likely due to
nutritional deficiency and results in poor foetal outcomes
including low birth weight (Hamalainen et al, 2003). Mothers
who were anaemic in the first trimester were excluded from this
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yanalysis (four cases, three controls). Mothers with no haemoglobin
values from the second or third trimester were also excluded (54
cases, 32 controls).
RESULTS
Haemoglobin values were available for 229 cases and 207 controls;
48 case mothers were anaemic compared to 47 controls. We found
no evidence that a maternal haemoglobin concentration of
o11gdl
 1 at any time during pregnancy was associated with
increased odds of infant leukaemia (data not shown). Applying
more stringent criteria for anaemia (haemoglobin o10gdl
 1),
dividing the haemoglobin concentration into categories (mild vs
severe anaemia), and evaluating haemoglobin concentration as a
continuous variable, also did not affect the results (data not
shown).
Further evaluation was performed for the physiologic anaemia
of pregnancy. A total of 178 case and 180 control mothers were
included in this analysis. Of these cases, 115 were ALL (71 MLLþ)
and 63 were AML (21 MLLþ).
Baseline characteristics were assessed for the 358 women
included in this analysis (see Table 1). There was a significant
difference in maternal race; more case mothers were Hispanic than
control mothers (5.6 vs 1.7%, P¼0.004). There was also a
statistically significant difference in maternal age and birth order
of the index child (see Table 1).
Overall, the unadjusted OR for physiologic anaemia of
pregnancy and risk of infant leukaemia was 0.85 (95% confidence
interval (CI) 0.53–1.37) (see Table 2). The association remained
non-significant when cases were divided into AML (n¼63) and
ALL (n¼115), with ORs of 0.64 (95% CI 0.32–1.30) and 0.98 (95%
CI 0.58–1.66), respectively. There was no association when cases
were stratified by MLL status (MLLþ OR 0.77; 95% CI 0.42–1.40,
MLL  OR 0.88; 95% CI 0.45–1.73). There was also no association
when the data were adjusted for maternal race and birth order.
Other variables did not significantly alter the association and were
not included in the final model.
DISCUSSION
We found no evidence for increased odds of infant leukaemia in
the offspring of mothers with a haemoglobin concentration of
o11gdl
 1 during pregnancy. Three previous studies found a
positive association between maternal anaemia and childhood
leukaemia. A case–control study of 153 cases of acute leukaemia
diagnosed in children from birth to 14 years of age in Greece from
1993 to 1994 used maternal report of anaemia during pregnancy
and found a positive association (OR 2.6; 95% CI 1.39–4.86)
(Petridou et al, 1997). Another group analysing leukaemia cases
qin England found an association in two case–control studies
(Roman et al, 1997, 2005). The more recent study compared 1485
children with leukaemia with 4864 controls. They found an OR of
2.6 (95% CI 1.7–4.1) for AML in children whose mothers had
haemoglobin of o10gdl
 1 during pregnancy. This included 25
children with AML whose mothers were anaemic. Interestingly,
this diagnostic group had a high median birth weight (3656g),
which was heavier than any other group in the analysis (Roman
et al, 2005).
Our findings cannot confirm these studies as these covered all
childhood leukaemias whereas our study concerned only infant
leukaemia. It is possible the association seen previously does not
exist for infant leukaemia. Also, in our North American patient
population, prenatal care may differ from those in the earlier
European studies. Our study subjects had essentially uniform use
of prenatal vitamins, iron and folate supplementation.
One weakness of our study is the lack of power. At 80% power,
the study is only capable of detecting an OR of about 2.0 or greater.
Subtler increases could be missed. A potential source of bias is the
selective enrolment of eligible RDD identified controls (59% field
response rate). There were significant differences between cases
and controls with respect to maternal race, maternal age and birth
order (see Table 1). Although adjustment for these factors did not
appreciably affect the risk estimates, we cannot rule out residual
confounding. A strength of this study is the use of medical records
to determine haemoglobin concentrations, which eliminates
maternal recall bias.
Despite the negative findings for this study, the plausible
associations of maternal anaemia during pregnancy, high birth
Table 1 Baseline characteristics of cases and controls with medical
record data
Cases
(n¼178) (%)
Controls
(n¼180) (%) P-value
Maternal education
pHigh school 36.5 27.8 0.08
4High school 32.0 36.7
XCollege graduate 31.5 35.6
Household income
o$30000 36.2 27.8 0.09
$30000–$75000 46.3 48.3
4$75000 17.5 23.9
Maternal race
White 79.2 86.7 0.004
Black 2.3 5.0
Hispanic 11.2 3.3
Other 7.3 5.0
Smoked during pregnancy 18 20.6 0.53
Maternal age at birth of index child 28.7 30.2 0.007
Average birth weight 3503g 3467g 0.52
Average birth order
(no. of previous live births)
0.84 1.1 0.02
Average minimum hemoglobin
concentration
11.69 11.60 0.42
Table 2 Association between anaemia during pregnancy (haemoglobin
concentration o11gdl
 1) and infant leukaemia
Odds ratio
(95% CI) unadjusted
Adjusted
a ODDS
ratio (95% CI)
Overall leukaemia (n¼178) 0.85 (0.53–1.37) 0.93 (0.57–1.53)
AML (n¼63) 0.64 (0.32–1.30) 0.67 (0.32–1.37)
ALL (n¼115) 0.98 (0.58–1.66) 1.14 (0.65–2.01)
MLL+ (n¼92) 0.77 (0.42–1.40) 0.88 (0.47–1.63)
MLL  (n¼62) 0.88 (0.45–1.73) 0.96 (0.48–1.91)
AML/MLL+ (n¼21) 0.46 (0.13–1.64) 0.57 (0.16–2.07)
AML/MLL  (n¼29) 0.72 (0.28–1.88) 0.70 (0.26–1.89)
ALL/MLL+ (n¼71) 0.87 (0.46–1.65) 0.98 (0.50–1.91)
ALL/MLL  (n¼33) 1.04 (0.45–2.39) 1.33 (0.55–3.24)
aAssociation is adjusted for maternal race (white, black, Hispanic and other) and birth
order (number of live births prior to index child). Maternal education (pHS, 4HS
ocollege grad, Xcollege grad), household income (o$30000, $30000–$75000,
4$75000), maternal age at time of index child’s birth, child gender, smoking during
pregnancy and birth weight were not significant confounders and are not included in
the adjusted model.
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for aetiology research. This study was inadequately powered to
detect subtle associations and should be repeated with a larger
sample size.
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